MS
Morgan Stanley
MS has the edge over PKBK overall, supported by stronger modeled upside and stronger valuation.
PKBK
Parke Bancorp, Inc.
PKBK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
PKBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
PKBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PKBK.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
PKBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.74 | -28% |
| Fair | 7.5x | $29.95 | -8.6% |
| Current | 8.3x | $32.76 | — |
| Expensive | 8.9x | $35.32 | +7.8% |
Historical ranges are pointers, not guarantees.
PKBK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
PKBK Forward outlook
There aren't enough analyst estimates for PKBK to show an outlook.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over PKBK on earnings, with more consistent year-over-year improvement.
PKBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.97 | +40% |
| Q2 2026 | $3.84 | +49% |
| Q1 2026 | $3.50 | +45% |
| Q4 2025 | $3.16 | +39% |
| Q3 2025 | $2.84 | +21% |
| Q2 2025 | $2.57 | +43% |
| Q1 2025 | $2.41 | +24% |
| Q4 2024 | $2.27 | -3.4% |
PKBK earned $3.97 per share over the past year, up 40% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
PKBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24M | +14% |
| Q2 2026 | $23.9M | +28% |
| Q1 2026 | $23M | +32% |
| Q4 2025 | $22.7M | +36% |
| Q3 2025 | $21M | +34% |
| Q2 2025 | $18.7M | +20% |
| Q1 2025 | $17.4M | +15% |
| Q4 2024 | $16.8M | -1.4% |
PKBK's revenue has grown year over year for seven quarters in a row: $24M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 68% | +3.6 points |
| Q2 2026 | 68% | +9.2 points |
| Q1 2026 | 68% | +8.6 points |
| Q4 2025 | 64% | +6.2 points |
| Q3 2025 | 64% | +4 points |
| Q2 2025 | 59% | +2.3 points |
| Q1 2025 | 59% | +3.7 points |
| Q4 2024 | 58% | -7.6 points |
PKBK has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
PKBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13M | +16% |
| Q2 2026 | $5.9M | -12% |
| Q1 2026 | $13M | +96% |
| Q4 2025 | $14.4M | +70% |
| Q3 2025 | $11.2M | +20% |
| Q2 2025 | $6.7M | -24% |
| Q1 2025 | $6.6M | -21% |
| Q4 2022 | $9.1M | -0.4% |
PKBK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over PKBK on shareholder dilution, with a more favorable share count trend.
PKBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +29.9K shares |
| 1 year | 0% | -5.8K shares |
| 3 years | -1.5% | -180K shares |
| 5 years | -1.4% | -173K shares |
| Available history | -0.5% | -58.8K shares |
PKBK has 12M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $6.5M |
| Q4 2024 | $2.2M |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
PKBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
PKBK has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
PKBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
| Stochastic | 29.8 | Neutral |
PKBK's weekly RSI is 54 (neutral) and its Stochastic is 30 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
PKBK PE vs Financial Services Sector
| Metric | PKBK | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 37% below |
| PE % | 63 | 63 | Same percentile |
PKBK has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
PKBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.8 | 0.1% below |
| 20 week MA | $33.5 | 2.1% below |
| 50 week MA | $30.4 | 7.7% above |
| 100 week MA | $25.4 | 29% above |
| 200 week MA | $21.9 | 50% above |
PKBK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 50% above its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
PKBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.9 | $15.4 | -33% |
| 2021 | $15.4 | $21.0 | +36% |
| 2022 | $21.0 | $20.6 | -2% |
| 2023 | $20.6 | $20.3 | -1.6% |
| 2024 | $20.3 | $20.7 | +2.1% |
| 2025 | $20.7 | $24.8 | +20% |
| 2026 YTD | $24.8 | $32.8 | +32% |
PKBK has the edge over MS on returns for 2026, with the stronger performance.